Yubo International Biotech Ltd Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Yubo International Biotech Ltd quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q2 2024.
  • Yubo International Biotech Ltd Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$598K, a 62.9% decline year-over-year.
  • Yubo International Biotech Ltd Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$1.52M, a 85.6% decline year-over-year.
  • Yubo International Biotech Ltd annual Net Income (Loss) Attributable to Parent for 2023 was -$1.2M, a 0.82% increase from 2022.
  • Yubo International Biotech Ltd annual Net Income (Loss) Attributable to Parent for 2022 was -$1.2M, a 21.9% increase from 2021.
  • Yubo International Biotech Ltd annual Net Income (Loss) Attributable to Parent for 2021 was -$1.54M, a 117% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.52M -$598K -$231K -62.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$1.29M -$410K -$92.8K -29.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-19
Q4 2023 -$1.2M -$517K -$621K -599% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-12
Q3 2023 -$574K $6.29K +$244K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$818K -$367K +$124K +25.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$943K -$317K +$262K +45.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-19
Q4 2022 -$1.2M $104K +$501K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 -$1.71M -$238K +$98.5K +29.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$1.8M -$492K -$122K -32.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$1.68M -$579K -$140K -32% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$1.54M -$397K -$372K -1458% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$1.17M -$337K -$31.9K -10.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-16
Q2 2021 -$1.14M -$370K -$338K -1058% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-16
Q1 2021 -$801K -$439K -$298K -211% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-16
Q4 2020 -$503K -$25.5K +$8.52K +25% Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-19
Q3 2020 -$512K -$305K -$270K -771% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$242K -$31.9K +$2.05K +6.04% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$244K -$141K -$108K -327% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$136K -$34K -$1K -3.03% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-19
Q3 2019 -$135K -$35K +$2K +5.41% Jun 1, 2019 Aug 31, 2019 10-Q 2021-01-19
Q2 2019 -$137K -$34K +$11K +24.4% Mar 1, 2019 May 31, 2019 10-Q 2021-01-19
Q1 2019 -$148K -$33K -$18K -120% Dec 1, 2018 Feb 28, 2019 10-KT 2021-04-23
Q4 2018 -$130K -$33K +$10K +23.3% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-13
Q3 2018 -$140K -$37K +$6K +14% Jun 1, 2018 Aug 31, 2018 10-Q 2019-10-11
Q2 2018 -$146K -$45K -$2K -4.65% Mar 1, 2018 May 31, 2018 10-Q 2019-10-11
Q1 2018 -$144K -$15K +$99K +86.8% Dec 1, 2017 Feb 28, 2018 10-K 2019-06-12
Q4 2017 -$243K -$43K $0 0% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-11
Q3 2017 -$243K -$43K -$10K -30.3% Jun 1, 2017 Aug 31, 2017 10-Q 2018-10-12
Q2 2017 -$233K -$43K -$9K -26.5% Mar 1, 2017 May 31, 2017 10-Q 2018-07-16
Q1 2017 -$224K -$114K -$84K -280% Dec 1, 2016 Feb 28, 2017 10-K 2018-06-13
Q4 2016 -$140K -$43K -$12K -38.7% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-16
Q3 2016 -$128K -$33K +$5K +13.2% Jun 1, 2016 Aug 31, 2016 10-Q 2017-10-16
Q2 2016 -$133K -$34K -$3K -9.68% Mar 1, 2016 May 31, 2016 10-Q 2017-07-14
Q1 2016 -$130K -$30K -$4K -15.4% Dec 1, 2015 Feb 29, 2016 10-K 2017-06-14
Q4 2015 -$126K -$31K +$1K +3.13% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-13
Q3 2015 -$127K -$38K -$9K -31% Jun 1, 2015 Aug 31, 2015 10-Q 2016-10-12
Q2 2015 -$118K -$31K -$2K -6.9% Mar 1, 2015 May 31, 2015 10-Q 2016-07-12
Q1 2015 -$116K -$26K +$2K +7.14% Dec 1, 2014 Feb 28, 2015 10-K 2016-06-10
Q4 2014 -$118K -$32K -$5K -18.5% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-14
Q3 2014 -$113K -$29K -$3K -11.5% Jun 1, 2014 Aug 31, 2014 10-Q 2015-10-06
Q2 2014 -$110K -$29K -$4K -16% Mar 1, 2014 May 31, 2014 10-Q 2015-07-09
Q1 2014 -$106K -$28K -$2K -7.69% Dec 1, 2013 Feb 28, 2014 10-K 2015-06-15
Q4 2013 -$104K -$27K +$3K +10% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-14
Q3 2013 -$107K -$26K -$2K -8.33% Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-17
Q2 2013 -$105K -$25K -$2K -8.7% Mar 1, 2013 May 31, 2013 10-Q 2014-06-23
Q1 2013 -$103K -$26K -$7K -36.8% Dec 1, 2012 Feb 28, 2013 10-K 2014-06-06
Q4 2012 -$96K -$30K -$8K -36.4% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q3 2012 -$88K -$24K -$4K -20% Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-03
Q2 2012 -$84K -$23K $0 0% Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
Q1 2012 -$84K -$19K Dec 1, 2011 Feb 29, 2012 10-K 2013-06-12
Q4 2011 -$22K -$1K -4.76% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-16
Q3 2011 -$20K +$26K +56.5% Jun 1, 2011 Aug 31, 2011 10-Q 2012-10-16
Q2 2011 -$23K Mar 1, 2011 May 31, 2011 10-Q 2012-07-12
Q4 2010 -$21K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12
Q3 2010 -$46K Jun 1, 2010 Aug 31, 2010 10-Q 2011-10-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.